523 related articles for article (PubMed ID: 25425111)
1. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
Taffe MA; Creehan KM; Vandewater SA
Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
[TBL] [Abstract][Full Text] [Related]
2. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
3. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
[TBL] [Abstract][Full Text] [Related]
4. Interactions between cannabidiol and Δ
Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC
Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732
[TBL] [Abstract][Full Text] [Related]
5. Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.
Javadi-Paydar M; Nguyen JD; Kerr TM; Grant Y; Vandewater SA; Cole M; Taffe MA
Psychopharmacology (Berl); 2018 Sep; 235(9):2541-2557. PubMed ID: 29907926
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats.
Malone DT; Jongejan D; Taylor DA
Pharmacol Biochem Behav; 2009 Aug; 93(2):91-6. PubMed ID: 19393686
[TBL] [Abstract][Full Text] [Related]
7. Explication of CB
Nguyen JD; Creehan KM; Grant Y; Vandewater SA; Kerr TM; Taffe MA
Drug Alcohol Depend; 2020 Sep; 214():108166. PubMed ID: 32717503
[TBL] [Abstract][Full Text] [Related]
8. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
Parker LA; Kwiatkowska M; Burton P; Mechoulam R
Psychopharmacology (Berl); 2004 Jan; 171(2):156-61. PubMed ID: 13680081
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
[TBL] [Abstract][Full Text] [Related]
10. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
Todd SM; Arnold JC
Br J Pharmacol; 2016 Jan; 173(1):53-65. PubMed ID: 26377899
[TBL] [Abstract][Full Text] [Related]
11. Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
Varvel SA; Wiley JL; Yang R; Bridgen DT; Long K; Lichtman AH; Martin BR
Psychopharmacology (Berl); 2006 Jun; 186(2):226-34. PubMed ID: 16572263
[TBL] [Abstract][Full Text] [Related]
12. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
Fride E; Ponde D; Breuer A; Hanus L
Neuropharmacology; 2005 Jun; 48(8):1117-29. PubMed ID: 15910887
[TBL] [Abstract][Full Text] [Related]
13. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
Zuardi AW; Karniol IG
Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
O'Brien LD; Wills KL; Segsworth B; Dashney B; Rock EM; Limebeer CL; Parker LA
Pharmacol Biochem Behav; 2013 Jan; 103(3):597-602. PubMed ID: 23103902
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
16. Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.
Roser P; Vollenweider FX; Kawohl W
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):208-19. PubMed ID: 20218784
[TBL] [Abstract][Full Text] [Related]
17. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
Moore CF; Weerts EM
Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500
[TBL] [Abstract][Full Text] [Related]
19. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.
Myers AM; Siegele PB; Foss JD; Tuma RF; Ward SJ
Br J Pharmacol; 2019 May; 176(10):1552-1567. PubMed ID: 29338068
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]